{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:28:47Z","timestamp":1793651327382,"version":"4.5.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,11,2]],"date-time":"2027-11-02T00:00:00Z","timestamp":1825113600000},"content-version":"am","delay-in-days":336,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K23DK123408"],"award-info":[{"award-number":["K23DK123408"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R03DK139283"],"award-info":[{"award-number":["R03DK139283"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.amjmed.2026.06.008","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T16:20:15Z","timestamp":1782145215000},"page":"1711-1718","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Medications for alcohol use disorder in alcohol-associated liver disease: The role of gastroenterologist and hepatologist in treatment and outcomes"],"prefix":"10.1016","volume":"139","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3812-7686","authenticated-orcid":false,"given":"Tarek","family":"Aridi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4269-7945","authenticated-orcid":false,"given":"Brittany","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3906-7017","authenticated-orcid":false,"given":"Ashina","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2056-4909","authenticated-orcid":false,"given":"Samer","family":"Gawrieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8731-2370","authenticated-orcid":false,"given":"Archita P.","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2026.06.008_bib0001","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1111\/acer.12887","article-title":"Clinical impact of alcohol-related cirrhosis in the next decade: estimates based on current epidemiological trends in the United States","volume":"39","author":"Guirguis","year":"2015","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.amjmed.2026.06.008_bib0002","article-title":"M.ortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study","volume":"362","author":"Tapper","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.amjmed.2026.06.008_bib0003","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.cgh.2017.11.045","article-title":"Alcoholic liver disease replaces Hepatitis C virus infection as the leading indication for liver transplantation in the United States","volume":"16","author":"Cholankeril","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.amjmed.2026.06.008_bib0004","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1002\/hep.29887","article-title":"The high burden of alcoholic cirrhosis in privately insured persons in the United States","volume":"68","author":"Mellinger","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.amjmed.2026.06.008_bib0005","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/hep.30866","article-title":"D.iagnosis and treatment of alcohol-associated Liver Diseases: 2019 practice guidance from the American Association for the Study of Liver Diseases","volume":"71","author":"Crabb","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.amjmed.2026.06.008_bib0006","doi-asserted-by":"crossref","DOI":"10.1172\/JCI157780","article-title":"Distinct histopathological phenotypes of severe alcoholic hepatitis suggest different mechanisms driving liver injury and failure","volume":"132","author":"Ma","year":"2022","journal-title":"J Clin Invest"},{"key":"10.1016\/j.amjmed.2026.06.008_bib0007","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S2468-1253(19)30415-7","article-title":"O.utpatient management of alcohol-related liver disease","volume":"5","author":"Simonetto","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.amjmed.2026.06.008_bib0008","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.13014","article-title":"Incidence and progression of alcohol-associated liver disease after medical therapy for alcohol use disorder","volume":"5","author":"Vannier","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.amjmed.2026.06.008_bib0009","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000093","article-title":"Medications for alcohol use disorder improve survival in patients with hazardous drinking and alcohol-associated cirrhosis","volume":"7","author":"Rabiee","year":"2023","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.amjmed.2026.06.008_bib0010","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.2014.3628","article-title":"Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis","volume":"311","author":"Jonas","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2026.06.008_bib0011","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/HEP.0000000000000570","article-title":"Medications for alcohol use disorder promote abstinence in alcohol-associated cirrhosis: results from a systematic review and meta-analysis","volume":"79","author":"Gratacos-Gines","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.amjmed.2026.06.008_bib0012","doi-asserted-by":"crossref","DOI":"10.1097\/HEP.0000000000001720","article-title":"Real-world impact of AUD pharmacotherapy on healthcare utilization, cost, and cost-effectiveness in the United States","author":"Nguyen","year":"2026","journal-title":"Hepatology"},{"key":"10.1016\/j.amjmed.2026.06.008_bib0013","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1002\/hep.31042","article-title":"Impact of alcohol use disorder treatment on clinical outcomes among patients with cirrhosis","volume":"71","author":"Rogal","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.amjmed.2026.06.008_bib0014","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/apt.70237","article-title":"Safety and tolerability of injectable extended-release naltrexone for the management of alcohol use disorder in advanced alcohol-associated liver disease","volume":"62","author":"Diaz","year":"2025","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.amjmed.2026.06.008_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2020.10.026","article-title":"Provider attitudes and practices for alcohol screening, treatment, and education in patients with liver disease: a survey from the American association for the study of liver diseases alcohol-associated liver disease special interest group","volume":"19","author":"Im","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.amjmed.2026.06.008_bib0016","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s11894-025-01026-x","article-title":"Pharmacotherapy to prevent alcohol relapse in alcohol-associated liver disease","volume":"27","author":"Zhang","year":"2025","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.amjmed.2026.06.008_bib0017","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1056\/NEJMcp2402121","article-title":"A.ddressing alcohol use","volume":"392","author":"Krist","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2026.06.008_bib0018","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.14309\/ajg.0000000000003328","article-title":"Medications for alcohol use disorder are increasingly being prescribed in American patients with advanced liver disease","volume":"120","author":"Shenoy","year":"2025","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.amjmed.2026.06.008_bib0019","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jhep.2018.03.018","article-title":"Management of alcohol-related liver disease","volume":"69","author":"Clinical Practice Guidelines","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.amjmed.2026.06.008_bib0020","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.jhep.2021.06.019","article-title":"Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: a worldwide study","volume":"75","author":"Arab","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.amjmed.2026.06.008_bib0021","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000145","article-title":"M.anagement of alcohol use disorder in patients with chronic liver disease","volume":"7","author":"Mellinger","year":"2023","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.amjmed.2026.06.008_bib0022","doi-asserted-by":"crossref","first-page":"918","DOI":"10.14309\/ajg.0000000000001616","article-title":"Motivation to reduce drinking and engagement in alcohol misuse treatment in alcohol-related liver disease: a National health Survey","volume":"117","author":"Kann","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.amjmed.2026.06.008_bib0023","article-title":"Barriers and facilitators of alcohol use disorder treatment for alcohol-associated liver disease: a systematic review","author":"Kim","year":"2025","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.amjmed.2026.06.008_bib0024","doi-asserted-by":"crossref","DOI":"10.1093\/alcalc\/agag008","article-title":"A missed opportunity: a retrospective cohort study of alcohol use disorder pharmacotherapy in hospitalized patients","volume":"61","author":"Nazon","year":"2026","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.amjmed.2026.06.008_bib0025","article-title":"Safety of naltrexone in patients with cirrhosis","volume":"6","author":"Thompson","year":"2024","journal-title":"JHEP Rep"},{"key":"10.1016\/j.amjmed.2026.06.008_bib0026","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/acer.14609","article-title":"A cascade of care for alcohol use disorder: using 2015-2019 National Survey on Drug Use and Health data to identify gaps in past 12-month care","volume":"45","author":"Mintz","year":"2021","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.amjmed.2026.06.008_bib0027","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1111\/add.15357","article-title":"Treatment rates for alcohol use disorders: a systematic review and meta-analysis","volume":"116","author":"Mekonen","year":"2021","journal-title":"Addiction"},{"key":"10.1016\/j.amjmed.2026.06.008_bib0028","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000341","article-title":"Incidence, clinical characteristics, and risk factors associated with recurrent alcohol-associated hepatitis","volume":"7","author":"Patidar","year":"2023","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.amjmed.2026.06.008_bib0029","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cgh.2015.07.047","article-title":"Efficacy of psychosocial interventions in inducing and maintaining alcohol abstinence in patients with chronic liver disease: a systematic review","volume":"14","author":"Khan","year":"2016","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934326004961?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934326004961?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T19:55:17Z","timestamp":1793649317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934326004961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S0002934326004961"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2026.06.008","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medications for alcohol use disorder in alcohol-associated liver disease: The role of gastroenterologist and hepatologist in treatment and outcomes","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2026.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}